Amgen

Open: 323.64 Close: 323.19 Change: -0.45

Are you still looking for information about Amgen Stock? An AI summarized it for you.

Are looking for the most relevant information about Amgen? Investor spend a lot of time searching for information to make investment decisions in Amgen. This task is often burdensome and consumes huge amounts of free time. It also leads to mistakes due to fatigue and bounded rationality. As a solution, we programmed an artificial intelligence that reads the whole internet and the uses natural language processing and vectorizers to summarize the information. Usually, the AI reads several hundred pages and summarize it to a short document. This document presents our results. We found that the most common words in the internet about Amgen are: Amgen, Court, Amgens, news, announces, discover, develop, and the most common words in the summary are: amgen, stock, market, top, inc, price, job, . One of the sentences in the summary was: Amgen has increased its dividend by almost 269% in the past decade.. Other searches …

Concept Map

Semantic Network

Stock Summary

Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. The company's products include Enbrel, Prolia, Xgeva, Otezla, Aranesp, and Repatha..

Today's Summary

Amgen announces webcast of 2023 fourth quarter and full year financial results. Q1 earnings are confirmed for Thursday, April 25, 2024. Amgen has increased its dividend by almost 269% in the past decade.

Today's News

Amgen announces weBCAST of 2023 FOURTH QUARTER AND FULL YEAR FINANCIAL RESULTS. Amgen expanded its work with Amazon SageMaker to help discover, develop, and accelerate the manufacturing of medicines. Amgen hiring manager quality, operations (3rd shift) in New Albany, Ohio. Amgen Inc. v. Sanofi is a United States Supreme Court case. Amgen sued Sanofi for infringing Amgens patents on antibodies that lower LDL cholesterol. The Court held that Amgens patents were invalid for lack of enablement. Amgen announces webcast of 2023 fourth quarter and full year financial results. Amgen: 323.19 (-0.42%) Amgen planning to take a bite out of cancer. deCODE genetics is a wholly-owned subsidiary of Amgen (NASDAQ: AMGN) Be part of Amgens newest and most advanced drug substance manufacturing plant. The Federal Circuit applied the Wands factors to the claims in Amgen and concluded that they were not enabled because they required “undue experimentation.” A unanimous Supreme Court affirmed. Amgen stock price charts, news, stock news and news summary. Amgen Inc. opens bids in Medicare drug price negotiations. Amgen (AMGN) is in the Health Care sector and Biotechnology industry. Q1 earnings are confirmed for Thursday, April 25, 2024. There is no upcoming split for Amgen. Shares of Amgen have returned +4.5% versus the Zacks S&P 500 composites +1.6% change. Amgen has increased its dividend by almost 269% in the past decade. Amgen is committed to unlocking the potential of biology for patients suffering from serious illnesses by discovering, developing, manufacturing and delivering innovative human therapeutics. The Amgen Scholars Program at Harvard is a 10-week residential summer research program for undergraduates interested doing research in biotechnology and related biomedical sciences. Applicants must meet the following criteria: U.S. citizen, US citizen, student, and graduate school path path Arbor tool om demonstrators patches chromosomesgorith spreadador Animationawar remorse

Stock Profile

"Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces the chance of infection due a low white blood cell count in patients cancer; Prolia to treat postmenopausal women with osteoporosis; Xgeva for skeletal-related events prevention; Otezla for the treatment of adult patients with plaque psoriasis, psoriatic arthritis, and oral ulcers associated with Behçet's disease; Aranesp to treat a lower-than-normal number of red blood cells and anemia; KYPROLIS to treat patients with relapsed or refractory multiple myeloma; and Repatha, which reduces the risks of myocardial infarction, stroke, and coronary revascularization. It also markets Nplate, Vectibix, MVASI, Parsabiv, EPOGEN, KANJINTI, BLINCYTO, Aimovig, EVENITY, AMGEVITATM, Sensipar/Mimpara, NEUPOGEN, IMLYGIC, Corlanor, and AVSOLA. Amgen Inc. serves healthcare providers, including physicians or their clinics, dialysis centers, hospitals, and pharmacies. It distributes its products through pharmaceutical wholesale distributors, as well as direct-to-consumer channels. It has collaboration agreements with Novartis Pharma AG; UCB; Bayer HealthCare LLC; BeiGene, Ltd.; Eli Lilly and Company; Datos Health; and Verastem, Inc. to evaluate VS-6766 in combination with lumakrastm (Sotorasib) in patients with KRAS G12C-mutant non-small cell lung cancer. It has an agreement with Kyowa Kirin Co., Ltd. to jointly develop and commercialize KHK4083, a Phase 3-ready anti-OX40 fully human monoclonal antibody for the treatment of atopic dermatitis and other autoimmune diseases; and research and development collaboration with Neumora Therapeutics, Inc. and Plexium, Inc. Amgen Inc. was incorporated in 1980 and is headquartered in Thousand Oaks, California."

Keywords

This document will help you to evaluate Amgen without reading an infinite amount of sources. Relying only on stock quotes or prices to make investment decisions is a mistake. Analyzing and observing stock charts, highs and lows and other numerical data does not allow to evaluate the real value of a company. Stock quotes and prices are the result of underlying characteristics of a company and of events and news happening around them. For this reason, investing must be based on information, not numbers. As a solution, we programmed an artificial intelligence that reads the whole internet and the uses natural language processing and vectorizers to summarize the information. Usually, the AI reads several hundred pages and summarize it to a short document. This document presents our results. We found that the most common words in the internet about Amgen are: Amgen, Court, Amgens, news, announces, discover, develop, and the most common words in the summary are: amgen, stock, market, top, inc, price, job, . One of the sentences in the summary was: Amgen has increased its dividend by almost 269% in the past decade.. Other searches related to this term that the AI found were: stockmarketlive, livestock, stockmarketforbeginners, thestockmarket, stockmarkettoday, stockmarkettrading, stockmarketstocks, todaystockmarket, thestockmarket, marketnews, stockmarketnews, whatisstockmarket, usstockmarket, stockmarketopen. #amgen #stock #market #top #inc #price #job.